ProfileGDS4718 / 244614_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 9% 15% 11% 8% 10% 8% 11% 17% 6% 19% 12% 6% 24% 14% 12% 9% 9% 9% 7% 6% 11% 8% 4% 11% 13% 11% 10% 18% 2% 14% 6% 10% 13% 6% 11% 9% 9% 16% 14% 6% 14% 9% 16% 14% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.774389
GSM549102patient 115, normal, homogenized [OPG study]3.963915
GSM549104patient 119, normal, homogenized [OPG study]3.7955111
GSM549108patient 138, normal, homogenized [OPG study]3.713538
GSM549119patient 077, normal, homogenized [OPG study]3.7929610
GSM549133patient 032, cancer, homogenized [OPG study]3.668158
GSM549139patient 042, cancer, homogenized [OPG study]3.8075911
GSM549099patient 107, normal, homogenized [OPG study]4.046817
GSM549109patient 139, normal, homogenized [OPG study]3.646876
GSM549110patient 046, normal, homogenized [OPG study]4.1233319
GSM549114patient 063, normal, homogenized [OPG study]3.8323212
GSM549122patient 082, normal, homogenized [OPG study]3.636116
GSM549134patient 033, cancer, homogenized [OPG study]4.2989224
GSM549136patient 036, cancer, homogenized [OPG study]3.896514
GSM549140patient 044, cancer, homogenized [OPG study]3.8071612
GSM549111patient 047, normal, homogenized [OPG study]3.710149
GSM549113patient 057, normal, homogenized [OPG study]3.718829
GSM549132patient 031, cancer, homogenized [OPG study]3.737449
GSM549137patient 038, cancer, homogenized [OPG study]3.657027
GSM549142patient 047, cancer, homogenized [OPG study]3.665386
GSM549100patient 110, normal, homogenized [OPG study]3.7997211
GSM549107patient 135, normal, homogenized [OPG study]3.668998
GSM549115patient 068, normal, homogenized [OPG study]3.508364
GSM549116patient 072, normal, homogenized [OPG study]3.7983111
GSM549120patient 078, normal, homogenized [OPG study]3.8908913
GSM549131patient 030, cancer, homogenized [OPG study]3.7966811
GSM549118patient 074, normal, homogenized [OPG study]3.7705610
GSM549129patient 027, cancer, homogenized [OPG study]4.0676618
GSM549123patient 088, normal, homogenized [OPG study]3.477312
GSM549124patient 006, cancer, homogenized [OPG study]3.9571614
GSM549126patient 015, cancer, homogenized [OPG study]3.592366
GSM549128patient 025, cancer, homogenized [OPG study]3.7590810
GSM549103patient 117, normal, homogenized [OPG study]3.9087913
GSM549117patient 073, normal, homogenized [OPG study]3.625976
GSM549138patient 041, cancer, homogenized [OPG study]3.7915511
GSM549141patient 045, cancer, homogenized [OPG study]3.697869
GSM549130patient 028, cancer, homogenized [OPG study]3.751639
GSM549101patient 111, normal, homogenized [OPG study]3.9902116
GSM549105patient 128, normal, homogenized [OPG study]3.9289114
GSM549106patient 134, normal, homogenized [OPG study]3.585626
GSM549112patient 048, normal, homogenized [OPG study]3.9223914
GSM549125patient 011, cancer, homogenized [OPG study]3.733629
GSM549127patient 024, cancer, homogenized [OPG study]3.9606816
GSM549135patient 035, cancer, homogenized [OPG study]3.8687114